ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Flavor Start-ups To Combine

by Melody M. Bomgardner
November 24, 2014 | APPEARED IN VOLUME 92, ISSUE 47

Evolva, a Swiss developer of biosynthetically derived small molecules, has acquired citrus-flavor producer Allylix in an all-stock deal worth approximately $63 million. Both firms specialize in making high-value molecules from sugar using modified strains of yeast. Evolva’s molecules span the flavors, fragrance, and personal care industries. It has a collaboration with International Flavors & Fragrances to market vanillin made via fermentation. It also plans to commercialize fermentation-derived resveratrol for use in supplements and saffron components for use in food. Meanwhile, Allylix has developed and scaled up fermentation production of nootkatone, a grapefruit flavor and fragrance, and an orange flavor called valencene. In addition, Allylix’s pipeline includes a new route to sandalwood oil, an expensive fragrance ingredient. The two firms say they will combine their efforts to make lower-cost natural sweeteners based on molecules found in the stevia plant. Combined, they have more than 400 patents.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment